An interventional study of Mindfulness Meditation Training in Sleep Disturbance and Arthropathy, sponsored by Colorado Joint Replacement. Completed at 1 site in United States. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-11-04.
Sponsored by Colorado Joint Replacement · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 149 studies in Joint Diseases with a site in United States — 15 open to participants now, 27 under way, 5 of them phase 3. Joint Diseases · United States.
Among the 149 studies in Joint Diseases with a site in United States, this one is the 40th largest by enrollment of the 118 interventional ones that give a count, is one of 7 that started in 2022, is one of 52 with no phase, and was the 127th registered.
386 studies on the registry are indexed under Joint Diseases; 64 are open to participants now.
Browse Joint Diseases studies →15 of the 149 studies in Joint Diseases with a site in United States are open now. Recruiting first, the newest first:
Restor3D · Sites in United States
Ages 18+
The University of Texas Medical Branch, Galveston · Sites in United States
Ages 18+
North Texas Medical Research Institute, PLLC · Sites in United States
Ages 30–85
Shirley Ryan AbilityLab · Sites in United States
Ages 50–75
Emory University · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 44 Joint Diseases studies recruiting now, 24 (55%) set no upper age limit and 11 (25%) stop at 75 or younger; 3 take children under 18; 1 takes healthy volunteers.
This study: 18 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
149 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 12 · Phase 2 21 · Phase 3 26 · Phase 4 11
First in 1991; this study’s year is marked. 7 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 282 is above the median of 102 across 251 interventional studies indexed under Joint Diseases.
Median enrollment 163 across the 118 interventional studies, 115 across the 30 observational. Of the 111 that completed or were terminated, 60 (54%) have results posted.
This tab as a report to print or save as PDF → With an account.
77 of 149 have an industry lead sponsor. The 10 most frequent:
Colorado Joint Replacement is the lead sponsor of 10 studies on the registry; none are open to participants now.
Colorado Joint Replacement has 2 studies filed under Joint Diseases — fewer than ten, so there is no comparison to draw.
6 of the studies in Joint Diseases with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06550024CrannMedSakuraBead Used as Resorbable Embolic for Genicular Artery Embolization | 2026-12 |
| NCT07553273The University of Texas Medical Branch, GalvestonVibratory Anesthesia on Pain Following Corticosteroid Injections | 2027-04 |
| NCT07008690University of MinnesotaMRI of the TMJ in Patients With DJD | 2027-05-31 |
| NCT02351414MicroPort Orthopedics Inc.Post Market Follow-Up Study of the EVOLUTION® Total Knee Arthroplasty System With Cruciate Sacrificing Inserts | 2027-06 |
| NCT05292339Emory UniversityKetorolac in Upper Extremity Tendinopathy and Arthropathy | 2027-07 |
Add all 6 to your calendar (.ics) → With an account.
Among the 149 studies in Joint Diseases with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The primary purpose of this study is the determine whether a 15 minute Mindfulness Meditation (MM) administered at the preoperative appointment prior to primary unilateral total joint arthroplasty (TJA) results in any improvement in Pittsburg Sleep Quality Index (PSQI) score, a validated metric for sleep quality, at 2, 6 or 12 weeks post-operatively.
The primary purpose of this study is the determine whether a 15 minute Mindfulness Meditation (MM) administered at the preoperative appointment prior to primary unilateral total joint arthroplasty (TJA) results in any improvement in Pittsburg Sleep Quality Index (PSQI) score, a validated metric for sleep quality, at 2, 6 or 12 weeks post-operatively. We hypothesize that patients in the MM cohort will have lower PSQI scores, indicating higher sleep quality, at both post-operative time points. Secondary aims include characterizing differences between cohorts in Visual Analog Scale (VAS) for pain, Epworth Sleepiness Scale (ESS) scores, Patient Reported Outcome Measurement Information System - Sleep Disturbance - Short Form, and Knee Injury and Osteoarthritis Outcome Scores (KOOS) at 2, 6 and 12 weeks following TJA.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patient will receive no mindfulness meditation training.
Patient will receive a one time training at their pre-operative appointment.
Behavioral: Mindfulness Meditation Training
Mindfulness Video Training at Pre-Op, 1 Day Prior to surgery, 3 day's Post OP and 2 Weeks Post OP.
Behavioral: Mindfulness Meditation Training
Patient will watch a 10 minute video on how to use mindfulness meditation to help with sleep after a total joint replacement procedure.
Pittsburg Sleep Quality Index score
Improvement in Pittsburg Sleep Quality Index (PSQI) score, Scale is 0 to 21, higher score is worse outcome.
Time frame: Change from Pre-Op to 2, 6 and 12 weeks post op.
Visual Analog Score
Improvement in Visual Analog Score (VAS), Scale is 1 to 10, higher score is worse outcome
Time frame: Change from Pre-Op to 2, 6 and 12 weeks post op.
Epworth Sleepiness Scale
Improvement in Epworth Sleepiness Scale (ESS), Scale is 0 to 24, higher score is worse outcome
Time frame: Change from Pre-Op to 2, 6 and 12 weeks post op.
Knee Injury and Osteoarthritis Outcome Scores JR
Improvement in Knee Injury and Osteoarthritis Outcome Scores JR (KOOS JR), Scale is 1 to 100, lower score is worse outcome
Time frame: Change from Pre-Op to 2, 6 and 12 weeks post op.
Knee Society Score (KSS)
Improvement in Knee Society Score (KSS), Scale is 0 to 100, lower score is worse outcome
Time frame: Change from Pre-Op to 6 Weeks post op.
Patient Reported Outcome Measurement Information System - Sleep Disturbance (PROMIS-SD)
Improvement in Patient Reported Outcome Measurement Information System - Sleep Disturbance (PROMIS-SD), Scale is 8 to 40, higher score is worse outcome
Time frame: Change from Pre-Op to 2, 6 and 12 weeks post op.
Ran from Mar 2022 to primary completion in Nov 2023, 20 months.
Of 80 non-industry interventional studies with no phase under Joint Diseases, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 57. This study's 20 months is below that.
Counting every sponsor, half of 99 studies reached it within 28 months; a quarter within 13 and three quarters within 59.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 4, 2026: primary completion Mar 2024 → Nov 2023 and completion Jul 2024 → Nov 2025.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Colorado Joint Replacement